My take on the Aruda settlement: it appears that the issue
My take on the Aruda settlement: it appears that the issue under dispute was whether Aruda was doing "work for hire" -- which means he was doing work in return for compensation, which gives someone NO intellectual property rights to the work that is done -- or whether he was doing work in which he was entitled to a share of the intellectual property.
None of us know the terms on which Aruda was hired, so we can't make an informed opinion of whether or not is was "work for hire." However, I think it is entirely possible that a person growing up in a different country (Menon) might not understand the complexities of American patent law, and would assume that Aruda was hired under a "work for hire" basis, while Aruda thought that he was entitled to a share of the profits. There are all kinds of questions involved in this, and we haven't seen any contracts or employment agreements so we don't know. However it seems perfectly logical that there was a genuine misunderstanding between the parties, and that Menon made this agreement to take off the burden of the lawsuit which was hanging over the company (even if he might have prevailed in court, many years down the line). Or he may have received advice from his lawyers that in fact he (Menon) had screwed up in whatever terms of employment he had made with Aruda, and that he WAS liable. I doubt that we will ever be privy to that information.
I have been asked to sign over intellectual property as "work for hire" stuff that I developed by myself before the involvement of the other company, and have refused when I asked an attorney about what "work for hire" entailed -- so I do have a pretty good working knowledge of this issue. It's complex and easy to see how two people could have completely different understandings of the rights involved.
My OPINION is that if I were running a research project and hired someone to help, I would assume he had no rights to the product of the work that I had devised, designed, raised money for, and hired him to help with. Wouldn't you?
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...
Continue Reading
Unleashing Innovation Through Specialized Apps Oh boy, it's about time someone shook things up in the research game. BC Platforms has rolled out the BC Mosaic App Store, a move that's got research types buzzing from Zurich to... well, anywhere healthcare pokes its head. These guys aren't just throwing out some generic, run-of-the-mill tools. No sir, they've created a...
Continue Reading
Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...
Continue Reading
stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...
Continue Reading
A Storm Brews Over Power Solutions International Look, if you're holding Power Solutions International (NASDAQ:PSIX) in your portfolio, it's time to perk up. The air's thick with talk that Kuehn Law, the firm with a head for shareholder litigation, is on their case. They're poking around, seeing if some executives got a little too creative with the truth. Word on the...
Continue Reading
The Edge Gets Real RMX Industries is tearing up the old rulebook of intelligence with their latest move. They’re calling it Real-World Intelligence, and right off the bat, RMX (OTCQB:RMXI) makes it clear they're not here to sell us some dusty data center illusion anymore. They're putting intelligence where the action is, at the physical edge, and that's something you...
Continue Reading
Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...
Continue Reading
The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...
Continue Reading
Understanding Razor Bumps: More Than a Cosmetic Annoyance Crossing Great Neck this morning, I stumbled across a curious release from Laser by Aleya. Apparently, the problem with those pesky razor bumps plaguing many isn't just skin-deep. For some, especially those with coarse or curly hair, each razor stroke starts a relentless cycle of irritation that's as grinding as...
Continue Reading
Roomba Max 875 Combo: Setting a New Standard Alright, folks, iRobot's at it again—unleashing what they tout as their beefiest cleaner to date, the Roomba Max 875 Combo Robot. It's a name that might twist your tongue, and this technological titan's feature list is equally complex. You know the routine with these fancy gadget launches: big promises, shiny features, but...
Continue Reading
Top 5 Most Recently Viewed Articles
Explore Sable Run: Affordable Living Awaits Century Communities is thrilled to introduce Sable Run, a vibrant new community set to offer accessible homeownership options for families and individuals. With prices beginning in the $300s, Sable Run intends to fulfill the growing demand for modern and affordable housing. Stunning Home Designs This community features two...
Continue Reading
IM Alliance Conference Promises Revolutionary Insights This year, the Independent Medical Alliance (IMA) is preparing to host its 4th Annual Conference with a pivotal theme that speaks volumes about the future of healthcare. Titled "Honest Medicine: Redefining Health," this event will take place from April 4-6 in a bustling setting. With a robust lineup of leading medical...
Continue Reading
Transformative Growth in Mobile Application Market The global mobile application market is anticipated to show substantial growth, with a predicted increase of USD 2.63 trillion from 2025 to 2029. The remarkable growth trajectory is attributed to the expanding smartphone penetration and advancements in technology, particularly artificial intelligence (AI) and machine...
Continue Reading
Orezone Gold's Ambitious Expansion Plan Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) recently made headlines with its bold move to fully exercise its over-allotment option related to a significant financing deal. By doing so, they secured an additional 6,402,450 common shares at a price of C$0.82 per share, which generated gross proceeds of C$5,250,009. Strategic Use...
Continue Reading
ASP Isotopes Inc. Public Offering Announcement In a significant move, ASP Isotopes Inc. (NASDAQ: ASPI) has announced the pricing of its underwritten public offering of common stock. The company plans to sell a total of 2,395,000 shares, priced at $6.75 each. This offering is projected to generate approximately $16.2 million for ASP Isotopes, before accounting for...
Continue Reading
